Funds holding ENSYSCE BIOSCIENCES INC
ISIN US2936025046 · United States
- Fund holders
- 2
- Of which ETFs
- 0 2 other funds
- Value held
- 24.1K $
- Share of capital
- 0.4 % of 19.5M shares on Aug 12, 2026
2 tracked funds declare this company. So these figures do not say who owns it.
| Fund | Shares | Value | Weight in fund | Share of capital | |
|---|---|---|---|---|---|
| Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 72,454 | 20.4K $ | 0.37 % | as of May 31, 2026 ↗ | |
| VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 12,854 | 3.7K $ | 0.07 % | as of Jun 30, 2026 ↗ |
Quarter after quarter
Each row is one quarter of SEC filings, newest first. The change compares each quarter with the one before.
| Quarter | Holders | Change | Shares | Change |
|---|---|---|---|---|
| 2026Q3 | 2 | -1 | 85,308 | +152.5 % |
| 2026Q2 | 3 | 0 | 33,783 | +49.3 % |
| 2026Q1 | 3 | 0 | 22,623 | -0.3 % |
| 2025Q4 | 3 | 0 | 22,681 | +152.2 % |
| 2025Q3 | 3 | 0 | 8,993 | +4.3 % |
| 2025Q2 | 3 | +2 | 8,625 | +611.6 % |
| 2025Q1 | 1 | 1,212 |
Institutional managers
13 managers declare this company to the SEC (Form 13F).
| Manager | Shares | Value | |
|---|---|---|---|
| ADAGE CAPITAL PARTNERS GP, L.L.C. | 149,711 | 80.6K $ | as of Mar 31, 2026 |
| PERCEPTIVE ADVISORS LLC | 86,666 | 46.7K $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 73,880 | 39.8K $ | as of Mar 31, 2026 |
| CITADEL ADVISORS LLC | 57,363 | 30.9K $ | as of Mar 31, 2026 |
| XTX Topco Ltd | 24,363 | 13.1K $ | as of Mar 31, 2026 |
| JANE STREET GROUP, LLC | 13,570 | 7.3K $ | as of Mar 31, 2026 |
| Virtu Financial LLC | 13,313 | 7 $ | as of Mar 31, 2026 |
| TRU INDEPENDENCE ASSET MANAGEMENT 2, LLC | 13,000 | 7K $ | as of Mar 31, 2026 |
| UBS Group AG | 8,791 | 4.7K $ | as of Mar 31, 2026 |
| Tower Research Capital LLC (TRC) | 6,094 | 3.3K $ | as of Mar 31, 2026 |
| FNY Investment Advisers, LLC | 3,000 | 1 $ | as of Mar 31, 2026 |
| SBI Securities Co., Ltd. | 486 | 262 $ | as of Mar 31, 2026 |
| BlackRock, Inc. | 65 | 35 $ | as of Mar 31, 2026 |
Declared shareholders of ENSYSCE BIOSCIENCES INC
There is 1 beneficial ownership filing. These stakes do not add up. An asset manager that files includes its own funds, which already appear among the funds on this page.
| Shareholder | Declared stake | Shares | |
|---|---|---|---|
| Bob Gene Gower | 6.10 % | 1,206,576 | as of Aug 7, 2026 · SCHEDULE 13D |
Cite this page
Titelia. "Funds holding ENSYSCE BIOSCIENCES INC". https://titelia.com/en/stocks/ensysce-biosciences-inc-US2936025046